Articles
RSSToday's Laboratory Information Management Systems Drive Business Decisions
November 9, 2008
•White Paper: Today's Laboratory Information Management Systems Drive Business Decisions
By Dave Champagne, Vice President and General Manager, informatics at Thermo Fisher Scientific
As seen in The Pharmaceutical Solutions Update, 2008 Fall Edition
As more and more data is generated, the challenge becomes not only capturing that data but also managing the data so it becomes useful information for the business. Consolidation of data systems is becoming increasingly important for those life sciences companies utilizing the services of contract research organizations (CROs) or establishing their own proprietary CROs in developing parts of the world that are far removed from their United States- or European-based headquarters. As LIMS have evolved, the centralization and harmonization of laboratory data also has become a critical and strategic part of the global growth of any pharmaceutical company.
Large-scale deployments of integrated and Web-based systems now can be relied upon to be more consistent and more rapid because purpose-built LIMS cannot only facilitate superior data exchange across the organizations, but also offer a bidirectional flow of data between a pharmaceutical company and any CRO performing studies on their behalf. This freer exchange of data can mean improved business decisions that enable a life sciences company to deliver the right compounds faster and saves the time and expense of working on a compound that ultimately will prove ineffective. It also allows for a faster and more automated review and submission of reports. Purpose-built LIMS prove valuable in simplifying routine system upgrades, dramatically minimizing project risks across sites, and sometimes enhancing compliance with the guidelines imposed by regulatory authorities.
Click Here To Download:•White Paper: Today's Laboratory Information Management Systems Drive Business Decisions
